CGL
RMD icon

Clarius Group LLC’s ResMed RMD Stock Holding History

Clarius Group LLC’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-978
Closed -$252K – 461
2025
Q2 		$252K Sell
978
-69
-7% -$16.5K 0.01% 401
2025
Q1 		$234K Sell
1,047
-24
-2% -$5.6K 0.01% 424
2024
Q4 		$245K Buy
1,071
+4
+0.4% +$963 0.02% 370
2024
Q3 		$260K Sell
1,067
-52
-5% -$11.6K 0.02% 353
2024
Q2 		$214K Sell
1,119
-101
-8% -$20.5K 0.02% 401
2024
Q1 		$242K Sell
1,220
-205
-14% -$37.6K 0.02% 406
2023
Q4 		$245K Buy
+1,425
New +$219K 0.02% 407
2023
Q3 		– Sell
-1,483
Closed -$324K – 509
2023
Q2 		$324K Sell
1,483
-19
-1% -$4.24K 0.03% 366
2023
Q1 		$329K Sell
1,502
-37
-2% -$8.03K 0.03% 361
2022
Q4 		$320K Buy
1,539
+82
+6% +$18K 0.03% 365
2022
Q3 		$318K Buy
1,457
+88
+6% +$20K 0.03% 325
2022
Q2 		$287K Buy
1,369
+132
+11% +$28.1K 0.03% 350
2022
Q1 		$322K Hold
1,237
– – 0.03% 340
2021
Q4 		$322K Buy
1,237
+65
+6% +$16.9K 0.03% 340
2021
Q3 		$309K Buy
1,172
+48
+4% +$13.1K 0.03% 311
2021
Q2 		$277K Buy
1,124
+26
+2% +$5.47K 0.02% 324
2021
Q1 		$213K Buy
1,098
+11
+1% +$2.21K 0.02% 353
2020
Q4 		$231K Buy
+1,087
New +$217K 0.02% 307

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Clarius Group LLC's RMD Position: Q3 2025 in Review

Clarius Group LLC sold out of ResMed (RMD) in Q3 2025, closing a stake of 978 shares — an estimated $252K sold.

Clarius Group LLC first reported a position in RMD in Q4 2020 and held it in 18 quarters. The position peaked at $329K in Q1 2023. 950 funds tracked by Wall St. Rank hold RMD as of Q3 2025.

  • Clarius Group LLC reported no remaining ResMed position as of Q3 2025 after selling out during the quarter.
  • Clarius Group LLC sold 978 ResMed shares in Q3 2025, an estimated $252K.
  • Clarius Group LLC first reported a position in ResMed in Q4 2020 and held it in 18 quarters.
  • Clarius Group LLC's ResMed position peaked at $329K in Q1 2023.
  • 950 funds tracked by Wall St. Rank held ResMed as of Q3 2025.

Based on Clarius Group LLC's 13F filing for Q3 2025, filed 14 Oct 2025.